Asthma and its Treatment

Keywords

Airways, Corticosteroids, Bronchial asthma

Introduction

Asthma is a significant and well known burden for all age groups. Even children are most affected by asthma. It is a disorder characterized by associate enlarged responsiveness of the airways to numerous stimuli leading to airway obstruction that's reversible either spontaneously or as a result of treatment. It is a chronic disease in which initially airways become swollen, and then they become narrow which leads to the difficulty in breathing. They can occur at any age [1-3].

Asthma is a chronic reversible reactive obstruction of lungs. It is a variable condition. Asthma is assumed to be caused by a mix of genetic and environmental factors [4]. To understand respiratory disease, it helps to understand how the airways work. These airways, or bronchial tubes, allow air to come in and out of the lungs. They become even more swollen and the muscles around the airways can tighten when something triggers your symptoms [5-8]. The inflammation makes the airways swollen and extremely sensitive. The airways tend to react powerfully to bound inhaled substances [9].

When the airways react, the muscles around them tighten. This narrows the airways, inflicting less air to flow into the lungs. The swelling can also worsen, creating the airways even narrower. Cells within the airways may build a lot of mucous secretion than usual [10-12]. Mucous secretion may be a sticky, thick liquid that may any slim the airways.

This chain reaction may result in respiratory disease symptoms. Symptoms will happen on every occasion the airways are inflamed [13].

Classification

Asthma was classified into intermittent and persistent

Intermittent

Intermittent bronchial asthma is the mildest type of asthma; however it's not a sort of asthma attack that's fully riskless. It is a most typical type of asthma in kids. In fact, within the most up-to-date asthma attack tips, the “mild” qualifier that antecedently was related to intermittent asthma attack has been removed to emphasize this terribly purpose. In intermittent asthma attack, impairment is low or absent. Symptoms are rare in intermittent asthma [15-18]. Some folks have their symptoms therefore typically they should have a preventer. As a result, patients with infrequent and mild symptoms of asthma should be treated intermittently with the aim of quick relief.

In fact, as a result of asthma attack, respiratory illness is outlined as a disease of chronic airway inflammation, in some ways that, the notion of intermittent asthma attack are a few things of a contradiction in terms [19]. Around seventieth of youngsters have infrequent intermittent bronchial asthma, which implies they need short, isolated episodes of bronchial asthma, typically in response to a respiratory tract infection or environmental substance. After all, however will a patient have intermittent, chronic airway inflammation? Clearly, intermittent asthma attack will exist, and relying upon the patient population in your apply; you'll see it often or sometimes. Still, several patients can have this manner of bronchial respiratory disorder as a result of milder types of asthma area unit most typical, and these gentle patients would require in progress clinical follow-up, acceptable medical management, and, like a lot of severely unhealthy patients, a transparent action arrange to follow [20-24].

Individuals with intermittent asthma attack can have minimal symptoms. Any level of symptoms that's bigger than this cannot match with the definition of intermittent asthma attack and can get to be treated with daily controller medication [25]. They'll have rare periods of exaggerated symptoms, and these “flares” won't end in the requirement for oral steroid medical care. Even once used during this fashion, a patient can still meet the standards for intermittent asthma attack as long as he or she isn't victimization the short- acting medicament for rescue.

Mild persistent

In gentle persistent respiratory disease, symptoms occur quite double every week however but once each day, and flare-ups might have an effect on activity. Night time flare-ups occur a lot than double a month however but once every week. Respiratory organ perform is eightieth of traditional or larger [26-29].

Exposure to chemicals, incorrect use of medicines and allergies can increase the risk of persistent asthma.

Persistent asthma was diagnosed by lung function tests, chest X ray.

Moderate Persistent

Asthma is classed as moderate persistent if symptoms occur daily. Flare-ups occur and typically last many days. Coughing and wheezy might disrupt the child’s traditional activities and create it troublesome to sleep [30]. Nighttime flare-ups might occur quite once per week. In moderate persistent respiratory illness, respiratory organ operate is roughly between hour and eightieth of traditional, while not treatment.

Severe persistent asthma

With severe persistent asthma attack, symptoms occur daily and sometimes. They conjointly of times curtail the child’s activities or disrupt his sleep [31]. Respiratory organ perform is a smaller amount than that of the conventional level while not treatment. Severe is that the least-common asthma attack level.
Some risk factors has been recognized which may lead to asthma. They are genetic characteristics, occupational exposures and environmental exposures [32-35].

Symptoms and Causes

Symptoms

• Coughing

• Wheezing

• Shortness of breath (Dysponea)

• Chest tightness [36-38].

Symptoms and severity of the disease change over time and in controlled conditions [36]. Asthma causes the recurring periods of symptoms [39]. Asthma can be cured and controlled with medications.

Causes

There are number of factors that are recognized to increase the chances of asthma, some of them are being overweight, smoker, allergic rhinitis and exposure to allergens [40-43].

Diagnosis

Asthma can be diagnosed by lung function test, allergy testing, chest x-ray, electrocardiogram etc.
Most children United Nations agency has respiratory disorder develop their 1st symptoms before five years more matured [44-49]. However, respiratory disorder in young youngsters (aged zero to five years) is laborious to diagnose. Sometimes it's laborious to inform whether or not a baby has respiratory disorder or another childhood condition [50]. This can be as a result of the symptoms of respiratory disorder conjointly occurring with different conditions. Also, several young youngsters United Nations agency wheeze after they get colds or metabolic process infections do not press on to possess respiratory disorder when they are six years previous. However, it's hard to do lung function tests in children younger than 5 years [51-57].

Treatment

Class of drugs used to treat asthma

Long-Term Therapy

Inhaled Corticosteroids

Cromolyn/Nedocromil

Leukotriene Modifiers

Oral Corticosteroids

Immediate Relief

Short-Acting Beta2 Agonists

Adjuvant Therapy

Long-Acting Beta2 Agonists

Methylxanthines [58-62]

Inhaled corticosteroids

Inhaled corticosteroids are the foremost effective medicine treatment out there for persistent respiratory disease [63]. These medications operate by suppressing the generation of cytokines, accomplishment of eosinophils, and unharness of inflammatory mediators. The clinical effects of those medications embrace reduction in symptom severity, improvement in peak breath flows, diminished airway hyper responsiveness [64-70], and potential interference of airway wall reworking. The dose of steroid hormone required varies looking on the particular product, delivery device and severity of the patient's respiratory disease. These medicines are employed in a metered-dose or dry powder dispenser. Inhalers could also be used otherwise, reckoning on the medication used.

There are some side effects by using these corticosteroids like oral trush, cough and dysponia. They may also have dose dependent adverse effects [71].

Cromolyn/Nedocromil

They have anti-inflammatory effects by blockading chloride channels. The modulations of somatic cell go- between unharness and white corpuscle accomplishment. Each medication will be employed in exercise- induced spasm and in gentle persistent asthma attack [72-75]. Nedocromil seems to be less assailable than cromolyn in inhibiting exercise-induced spasm. Cromolyn and Nedocromil area unit usually comparable in patients with gentle allergic asthma attack. Nedocromil could also be more practical in patients with non- allergic asthma attack taking inhaled corticosteroids and will facilitate to scale back the need for inhaled corticosteroids.

These drugs are safe profiled drugs [76].

Leukotriene Modifiers

Drugs that inhibit the 5-lipoxygenase enzyme will inhibit the synthetic pathway of leukotriene metabolism
[77].

They come beneath leukotriene receptor antagonists. Leukotriene modifiers stop the action of leukotrienes within the body. Leukotrienes square measure free from mast cells, basophils and eosinophils [78-83]. Leukotriene synthesis inhibitors stop synthesis of leukotrienes by obstruction the catalyst, 5-lipoxygenase that is critical for the formation of leukotrienes. They are used to prevent chronic asthma and allergic rhinitis.

Oral Corticosteroids

Systemic steroids can be useful in speeding resolution of asthma exacerbations. Oral corticosteroids relief inflammation and swelling within the airways. Throughout bronchial asthma, the thin walls of the airways swell and slender [84-89]. Reducing this swelling permits the airways to open up, permitting higher air flow.

Short-Acting Beta2 Agonists

These are bronchodilator which acts by relaxing the muscle linings the airways. Short-acting beta2 agonists square measure the medications of alternative in treating bronchial asthma exacerbations and exercise- induced spasm. The frequently scheduled, daily use of those medicines isn't counseled. The frequency of use of a beta2 agonist will be wont to assess the effectiveness of bronchial asthma treatment.

Long-Acting Beta2 Agonists

Long-acting beta2-agonists are recommended only in combination with a corticosteroid to treat asthma. These medications have a period of action of a minimum of twelve hours [89-95]. Long beta2 agonists are primarily to be used as adjuvant medical aid to medicament treatment. They will be used for semi- permanent symptom management and are notably helpful in treating nocturnal respiratory illness symptoms [96]. These medications are helpful in exercise-induced spasm.

Methylxanthines

Theophyline, the foremost common methylxanthine, causes delicate to moderate bronchodilation. Some recent proof suggests that theophyline may have a light anti-inflammatory drug part [97-101]. Sustained unleash Theophyline's principle use is as adjuvant medical aid and it's significantly helpful in dominant nocturnal symptoms. Though not a most well-liked choice, sustained-release theophyline will be used as primary treatment in some patients.

References

1. Simatovic J, et al. Characteristics of Individuals Admitted to the Intensive Care Unit for Asthma. J Pulm Respir Med. 2015; 5: 256.
2. Albarran C, et al. Guidelines and Asthma: Some Considerations for Third World Countries. J Pulm Respir Med. 2015; 5: 253.
3. Leung TF, et al. Novel Asthma Therapeutics: Insights from Whole-Genome Studies. J Pharmacogenom Pharmacoproteomics. 2013; 4: 115.
4. Liu HC, et al. House Dust Mite Allergy and Associated Allergen-Specific Immunotherapy in Allergic Asthma. Immunome Res. 2014; 11: 085.
5. Soni P and Sunil Kumar M. A Study on Prevalence of Tobacco Use among Children: A Literature Review. J Alcohol Drug Depend. 2015; 3: 187.
6. Cantani A. Children with Chronic Asthma Have a Significant Sensitization to Multiple Aeroallergens: A Prospective Study in 74 Children. Interdiscip J Microinflammation. 2014; 1: 124.
7. Nan Lv, et al. Weight Management Interventions in Adult and Pediatric Asthma Populations: A Systematic Review. J Pulm Respir Med. 2015; 5: 232.
8. Hudd TR, et al. Survey of Certified Asthma Educator (AE-C) Pharmacists – Who are they and how is this Credential Being Used?. J Pulm Respir Med. 2014; 4: 223.
9. Sahoo A, et al. E3 Ligases in T Helper 2-mediated Pathogenesis. Immunome Res. 2014; 11: 086.
10. Liu HC, et al. House Dust Mite Allergy and Associated Allergen-Specific Immunotherapy in Allergic Asthma. Immunome Res. 2014; 11: 085.
11. Soni P and Sunil Kumar M. A Study on Prevalence of Tobacco Use among Children: A Literature Review. J Alcohol Drug Depend. 2015; 3: 187.
12. Cantani A. Children with Chronic Asthma Have a Significant Sensitization to Multiple Aeroallergens: A Prospective Study in 74 Children. Interdiscip J Microinflammation 2014; 1: 124.
13. Nan Lv, et al. Weight Management Interventions in Adult and Pediatric Asthma Populations: A Systematic Review. J Pulm Respir Med 2015; 5: 232.
14. Hudd TR, et al. Survey of Certified Asthma Educator (AE-C) Pharmacists – Who are they and how is this Credential Being Used?. J Pulm Respir Med. 2014; 4: 223.
15. Sabbah I, et al. Influence of Air Quality Conditions on Asthmatic Patient Visits in Kuwait. J Allergy Ther. 2014; 5: 197.
16. Randhawa I, et al. No Correlation between Beta2-Adrenergic Receptor Polymorphisms and the Severity and Clinical Control of Geriatric Asthma and COPD. J Allergy Ther. 2014; 5: 196.
17. Mincarini M, et al. Allergen Specific Immunotherapy in Asthma. J Allergy Ther 2014; 5: 190.
18. Zedan M, et al. Single Nucleotide Polymorphism of IL4C-590T and IL4RA 175V and Immunological Parameters in Egyptian Asthmatics with Different Clinical Phenotypes. J Allergy Ther. 2014; 5: 189.
19. Puri A, et al. Asthma in HIV-Infected Population: A Review of Respiratory Symptoms, Pulmonary Function Abnormalities and Pathophysiology. Epidemiol. 2014; 4: 164.
20. Farid Shafei H, et al. Quality of Life in Some Asthmatic Children Treated with Homeopathic Remedies and their Parents. J Homeop Ayurv Med. 2014; 3: 159
21. Kazemi M and Malarvili MB. Analysis of Capnogram Using Linear Predictive Coding (LPC) to Differentiate Asthmatic Conditions. J Tissue Sci Eng. 2011; 2: 111.
22. Mickleborough TD and Lindley MR. The Effect of Combining Fish Oil and Vitamin C on Airway Inflammation and Hyperpnea-Induced Bronchoconstriction in Asthma. J Allergy Ther. 2014; 5: 184.
23. Vishvender S, et al. Preventive and Curative Aspect of Yoga in Management of Asthma in Children. J Homeop Ayurv Med. 2014; 3: 152.
24. Yap JMG, et al. Multiple House Dust Mite Allergen- Sensitization Profiles in Children with Allergic Asthma. J Allergy Ther. 2014; 5: 179.
25. Shirai T, et al. Exhaled Nitric Oxide Measurement may Predict Asthma Exacerbation after Stepping down Formoterol/Budesonide Combination Therapy in Adult Asthma. J Allergy Ther. 2014; 5: 173.
26. Brooks SM. Irritant-Induced Asthma and Reactive Airways Dysfunction Syndrome (RADS). J Allergy Ther. 2014; 5: 174.
27. MacRedmond R E, et al. Fluticasone Induces Epithelial Injury and Alters Barrier Function in Normal Subjects. J Steroids Hormon Sci. 2014; 5: 134.
28. McConaha JL. Evaluation of Student Pharmacist and Pharmacist Impact on Disease State Management and Patient Satisfaction in Adult Patients with Asthma. J Pharma Care Health Sys. 2014; 1: 106.
29. Akhtar J, et al. Incidence of Zeequn- Nafas Shoabi (Bronchial Asthma) in Individuals of Different Temperaments. J Homeop Ayurv Med. 2014; 3: 147.
30. Arrigo R and Scichilone N. The Effect of Immunotherapy in Allergic Respiratory Diseases: Reappraisal of Current Knowledge. J Allergy Ther. 2014; 5: 171.
31. Bantz SK, et al. The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma. J Clin Cell Immunol. 2014; 5: 202.
32. Chauhan BF, et al. Should we Substitute Intermittent for Maintenance Inhaled Corticosteroids in Patients with Persistent Asthma? A Systematic Review and Meta-Analysis. J Allergy Ther. 2013; 4: 155.
33. Li HJ, et al. IL-25 Involved in Airway Inflammation of OVA-Induced Asthmatic Mice and the Inhibitory Effect of Glucocorticoid. J Allergy Ther. 2013; 4: 151.
34. Bossé Y, et al. Airway Hyperresponsiveness in Asthma: A Better Understanding Yet to Yield Clinical Benefit. J Allergy Ther. 2013; 4: 150.
35. Avdalovic M, et al. Airway Vascularity is not Associated with Airway Hyper-responsiveness in a Non- human Primate Model of Asthma. J Allergy Ther. 2013; 4: 149.
36. Armengot M, et al. Eosinophils and Airway Inflammation. J Genet Syndr Gene Ther.2014; 5: 220.
37. Prado CM, et al. New Pharmacological Targets for Asthma Drug Development. J Allergy Ther. 2014; 5:170.
38. Ozdogan S, et al. A Comparison of Impulse Oscillometry to Spirometry in the Evaluation of Exercise Induced Bronchoconstriction in Children with Asthma. J Pulm Respir Med.2014; 4: 180.
39. Ishiura Y, Fujimura M, Kasahara K (2014) Eosinophilic Bronchial Disorders Presenting Chronic Cough; Atopic Cough, Cough Variant Asthma and Non-Asthmatic Eosinophilic Bronchitis. J Genet Syndr Gene Ther 5:217.
40. Ernst G, et al. Significant Increase of IL-8 Sputum Levels in Treatment Resistant Severe Asthma Compared with Difficult to Treat Severe Asthma Patients. J Genet Syndr Gene Ther. 2014; 5: 218.
41. Hassan WA, et al. Impact of Intensive Care Management of Life Threatening Asthma on Feto- Maternal Outcome. J Women’s Health Care. 2014; 3: 144.
42. Horner AA. Innate Immune Regulation of the Allergic March: Using House Dust to Validate the Hygiene Hypothesis. J Clin Cell Immunol. 2014; 5: 194.
43. Pelikan Z. Protective Effects of Oral Disodium Cromoglycate on the Asthmatic Responses Induced by Food Allergy. J Allergy Ther. 2014; 5: 163.
44. Possa SS, et al. Influence of Oral Tolerance on Lung Cytokines Expression and Oxidative Stress Activation in Guinea Pigs with Chronic Inflammation. J Allergy Ther. 2014; 5: 165.
45. Hasanloei MAV and Athari SS. Proper Care of Allergic Asthma before Hospitalization. J Allergy Ther. 2014; 5: 161.
46. Manuel V, et al. Ebstein’s Anomaly: An Impressive Cardiothoracic Ratio. J Cardiovasc Dis Diagn. 2015; 3: 188.
47. Kim S, et al. Efficacy of Dual Lung Cancer Screening by Chest X-Ray and Sputum Cytology Using Johns Hopkins Lung Project Data. J Biomet Biostat. 2012; 3:139.
48. Källén B. Maternal Asthma and Use of Antiasthmatic Drugs in Early Pregnancy and Congenital Malformations in the Offspring. J Pulm Respir Med. 2014; 4: 166.
49. Saeedi M, et al. Evaluation of Predictors of Admission in Asthmatic Patients in Emergency Department. Trop Med Surg. 2013; 1: 154.
50. Gandhi CS, et al. Assessment of Quality of Life in Children with Asthma and Epilepsy. Pediat Therapeut. 2013; 3: 175.
51. Dhillon RK, et al. Impact of Asthma on the Severity of Serious Pneumococcal Disease. Epidemiol. 2011; S3: 001.
52. Kamimura M, et al. Transdermal Application of Steroid to Cervical Trachea for the Cough in Patients with Bronchial Asthma and Cough Variant Asthma-A Pilot Study. J Allergy Ther. 2013; 4: 152.
53. Asai N, et al. A Successful Case of Persistent Asthma in the Treatment of Inhalation Corticosteroid Combination Therapy of Budesonide/Folmoterol and Ciclesonide. J Clin Case Rep. 2013; 3: 296.
54. Valadares MA, et al. Spirometry with FEV0.75 Increases the Sensitivity for the Diagnosis of Obstructive Disorder in Children of Asthmatic Mothers. J Aller Ther. 2013; S2:006.
55. Dembinski L, et al. Laryngopharyngeal Reflux and Asthma. J Aller Ther 2013; S11: 008.
56. Applegate R, et al. The Perioperative Management of Asthma. J Aller Ther. 2013; S11: 007.
57. Hassan BAR. Overview at Asthma. Nat Prod Chem Res. 2013; 1: e103.
58. Leung TF, et al. Novel Asthma Therapeutics: Insights from Whole-Genome Studies. J Pharmacogenom Pharmacoproteomics. 2013; 4:115.
59. Ammar ESM, et al. Chinese Propolis Attenuates In-Vivo and In-Vitro Asthmatic Reactions. J Aller Ther. 2013; S11:006.
60. Qian Z, et al. The Expression and Significance of CD4+T Lymphocyte in the Peripheral Blood of Patients with Asthma. J Aller Ther. 2013; S11: 005.
61. Asija A, et al. Bronchial Thermoplasty in Severe Asthma. J Aller Ther. 2013; 4: e107.
62. Ahmed A, et al. A Descriptive Analysis of Asthma Exacerbations and it’s Mortality in Karachi, Pakistan. J Aller Ther. 2013; S11: 004
63. Mahboub BH, et al. Cost of Asthma in Dubai, United Arab Emirates (UAE). J Pulmon Resp Med. 2013; 3: 146.
64. Xiao H, et al. The Importance of Bronchial Epithelial Junction Integrity in Asthma. J Aller Ther. 2013; S11: 003.
65. Hutchinson SG, Penders J, Muris JWM, van Schayck CP, Dompeling E, et al. (2013) Environmental Tobacco Smoke Exposure and Respiratory Complaints in Children Aged 0-13 Years: A Cross- sectional Study in South-Limburg, The Netherlands. J Aller Ther S11:002.
66. Onal O and Yilmaz S. Anesthesia Management in a Patient Diagnosed with Kounis-Zavras Syndrome and Who has Brittle Asthma and Samter Triad. J Clin Case Rep. 2013; 3: 254.
67. Insuela DBR, et al. The Yin Yang of Hormones that Control Glucose Homeostasis in Asthma. J Aller Ther. 2013; S11: 001.
68. Kannan Y and Wilson MS. TEC and MAPK Kinase Signalling Pathways in T helper (TH) cell Development, TH2 Differentiation and Allergic Asthma. J Clin Cell Immunol. 2012; S12: 011.
69. Price D, et al. Effect of Inhaled Corticosteroid Therapy Step-Down and Dosing Regimen on Measures of Asthma Control. J Aller Ther. 2013; 4: 126.
70. Earla P. Tuberculosis: A Terrible Transmitted Disease. J Mycobac Dis. 2014; 4: R1-001.
71. Albillos SM. Detection Problems Associated to Processed Food Allergens. 2012.
72. Wang LH and Liu HJ. Determination of Fragrance Allergens in Essential Oils and Evaluation of their in vitro Permeation from Essential Oil Formulations through Cultured Skin. J Bioequiv Availab. 2010; 2: 072-076.
73. Shindoh C, et al. Effects of Long-Acting β2-Agonist and Corticosteroid Inhalation on Diaphragm Muscle in Mice. J Drug Metab Toxicol. 2015; 5: 176.
74. Bivona L, et al. Non Infectious Cavitary Exogenous Lipoid Pneumonia: A Case-Based Short Review. J Pulm Respir Med. 2015; 5: 42.
75. Srinivasarao K, et al. Validated Method Development for Estimation of Formoterol Fumarate and Mometasone Furoate in Metered Dose Inhalation Form by High Performance Liquid Chromatography. J Anal Bioanal Tech. 2012; 3: 153.
76. Hayashi T. Molecular Mechanisms of Metaplasia, Differentiation and Hyperplasia of Goblet Cellin Allergic Asthma. J Aller Ther. 2012; 3: 121.
77. Rahman A, et al. Levosalbutamol versus Salbutamol for Treatment of Acute Exacerbation of Asthma in Bangladesh Children. J Aller Ther. 2012; 3: 123.
78. Isozaki A, et al. Detection of Asthmatic Cough on Basis of Bronchodilator Responsiveness by the Forced Oscillation Technique and 3-Dimentional Imaging: A Case Report. J Clin Case Rep. 2012; 2: 178.
79. Ramana KV, et al. Pulmonary Cryptococcosis Secondary to Bronchial Asthma Presenting as Type I Respiratory Failure- A Case Report with Review of Literature. Virol Mycol. 2012; 1: 107.
80. Fida NG, et al. Association of Age at Menarche and Menstrual Characteristics with Adult Onset Asthma among Reproductive Age Women. Reprod Sys Sexual Disorders. 2012; 1: 111.
81. Ohyama M, et al. Possible Link between Nitrous Acid and Asthma Induced by Fine Particles. J Clinic Toxicol. 2012; 2: e107.
82. Erbas B, et al. A Case-Crossover Design to Examine the Role of Aeroallergens and Respiratory Viruses on Childhood Asthma Exacerbations Requiring Hospitalization: The Mapcah Study. J Biomet Biostat. 2012; S7-018.
83. Askin D, et al. Spontaneous subcutaneous and muscular bleeding due to Acquired Hemophilia a in Association with Poorly- Controlled Asthma: A Case Report. J Blood Lymph. 2012; 2:107.
84. Rappaport H and Bonthapally V. The Direct Expenditures and Indirect Costs Associated with Treating Asthma in the United States. J Aller Ther. 2012; 3: 118.
85. Wu D. New Insights into the Pathological Features of Asthma/COPD and Pulmonary Arterial Hypertension. Air Water Borne Dis. 2012; 1:e113.
86. Loh LC. Risks of Long-Acting Beta-Agonist in Asthma-Perceived or Real?. J Pulmonar Respirat Med. 2012; 2: e115.
87. Kumar D, et al. Descriptive Study of Head Injury and its Associated Factors at Tertiary Hospital, Northern India. J Community Med Health Educ. 2012; 2: 141.
88. Torabi M. Spatial Disease Cluster Detection: An Application to Childhood Asthma in Manitoba, Canada. J Biomet Biostat. 2012; S7: 010.
89. Hostrup M, et al. Urine Concentrations of Inhaled Salmeterol and its Metabolite a- Hydroxysalmeterol in Asthmatic and Non-Asthmatic Subjects. J Sports Med Doping Stud. 2012; 2: 110.
90. Limb SL, et al. Irreversible lung function deficits in young adults with a history of childhood asthma. J Allergy Clin Immunol. 2005; 116:1213.
91. Burrows B, et al. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med. 1987; 317:1309.
92. Rijcken B and Weiss ST. Longitudinal analyses of airway responsiveness and pulmonary function decline. Am J Respir Crit Care Med. 1996; 154:S246.
93. Haahtela T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med. 1994; 331:700.
94. Darshan Patel, et al. An Alternative Aspirin Desensitization Protocol for Patients with Aspirin- Exacerbated Respiratory Disease. J Allergy Ther. 2015; 6: 207.
95. Zhong J, et al. Skin Prick Test Reactivity to Aeroallergens in Allergic Rhinitis Children in Guangzhou, Southern China. J Allergy Ther. 2014; 5: 178.
96. Morin C, et al. New Omega-3 Derivatives Reduce Airway Inflammation and Prevent Rho-Kinase Activation in an Allergic Model of Asthma. J Aller Ther. 2012; S1:003.
97. Theofilou P and Saborit AR. Predictors of Asthma Treatment Adherence. J Psychol Psychother. 2012; S3: e001.
98. Lowder TW and Kunz HE (2011) Regulatory T Cells in Asthma and Airway Hyperresponsiveness. J Aller Ther. 2011; S1:002.
99. Pinto S, et al. Erythrocyte and Plasma Antioxidants in Bronchial Asthma Before and After Homeopathic Treatment. J Homeopat Ayurv Med. 2012; 1:103.
100. Liu J, et al. Bronchiectasis in COPD: A New Phenotype of COPD with Particular Attention. J Pulm Respir Med. 2015; 5:226.
101. Chauhan BF, et al. Should we Substitute Intermittent for Maintenance Inhaled Corticosteroids in Patients with Persistent Asthma? A Systematic Review and Meta-Analysis. J Allergy Ther. 2013; 4:155.